Empego Technologies is a Montreal-based healthcare technology company founded in 2020. It specializes in digital solutions that enhance pharmacy workflows and optimize patient care. With a team of 10-50 employees, Empego has participated in the Creative Destruction Lab accelerator program.

The company’s main offering is a patient engagement platform designed by pharmacists. This platform features standardized clinical questionnaires for efficient triage and monitoring of various health conditions. It also includes workflow integration tools that allow pharmacists to provide advanced clinical services beyond traditional medication dispensing, as well as patient communication systems that improve health literacy and engagement.

Empego has partnered with Pharmaprix (Shoppers Drug Mart) to implement clinical pharmacy services across their network. This collaboration enables pharmacists to manage minor ailments and provide preventive care. Empego aims to be a leader in pharmacist-led clinical services in Canada, focusing on evidence-based practices to enhance patient outcomes and pharmacy efficiency under the leadership of CEO Philippe Chartrand.